{
    "clinical_study": {
        "@rank": "68656", 
        "brief_summary": {
            "textblock": "In this study we propose to test the Biofusionary Bebe in order to reduce skin laxity and\n      improve contour and cosmesis."
        }, 
        "brief_title": "Efficacy Study for Magnetic Induction to Treat Wrinkles", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Wrinkles and Rhytides", 
        "eligibility": {
            "criteria": {
                "textblock": "The inclusion criteria for the study are:\n\n          -  Male or female  21 to 65 years old,\n\n          -  Clinically appreciable skin laxity on the abdomen (including flank), face, neck,\n             hips, thighs, upper arms & buttocks as determined by the study investigator,\n\n          -  For females, post-menopausal, surgically sterilized, or using a medically accepted\n             form of birth control for at least 3 months prior to the study,\n\n          -  Apparently healthy,\n\n          -  Informed consent signed by the subject.\n\n        Exclusion Criteria:\n\n        The exclusion criteria for the study are:\n\n          -  History of skin hypersensitivity,\n\n          -  Current skin disorder (e.g. keloid scarring) or infection (e.g., herpes simplex) in\n             the treatment area,\n\n          -  Subjects with pacemakers, internal defibrillators or electronically, magnetically,\n             and mechanically activated implants,\n\n          -  Subjects with implanted medical prostheses (such as clips, pins or plates) proximal\n             to the treatment site,\n\n          -  The current or recent use (within the past 12 months) of isotretinoin,\n\n          -  Pregnancy,\n\n          -  Infectious diseases (such as HIV) present,\n\n          -  Are a tobacco smoker,\n\n          -  Insulin dependent diabetic subjects,\n\n          -  Oxygen dependent subjects,\n\n          -  Subjects with severe chronic illness, scleroderma, or lupus,\n\n          -  Subjects with open sores or scars in the treatment region, or\n\n          -  Subjects with ischemia in the treatment region."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701440", 
            "org_study_id": "0310-0017"
        }, 
        "intervention": {
            "intervention_name": "Biofusionary Bebe", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 10, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Physicians Laser and Dermatolgy Institute of Chicago,LLC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Radiofrequency Magnetic Induction Device for Use In Dermatologic Procedures for the Non-Invasive Treatment of Wrinkles and Rhytides", 
        "overall_official": {
            "affiliation": "Physicians Laser and Dermatology Institute of Chicago", 
            "last_name": "Jerome Garden, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Improvement in cosmesis will be assessed by scoring photographs taken before and 1 month after treatment. Circumference changes will be measured and compared", 
            "measure": "Improvement in cosmesis", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701440"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Improvement in cosmesis will be assessed by scoring photographs taken before and at 3 months after treatment. Circumference changes will be measured and compared.", 
            "measure": "Improvement in cosmesis", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Rocky Mountain Biosystems, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rocky Mountain Biosystems, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}